SSN-29882-65256
2 vaccinations
2 coded responses
13 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 280 / NC
- Registered
- 2022-05-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-05-26
Registered in v-safe
-
2022-05-26
Dose 1 — Pfizer-BioNTech
-
2022-05-26
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Headache, Muscle or body aches, DiarrheaAdult check-in
- 2022-05-28
-
2022-06-20
Dose 2 — Pfizer-BioNTech
-
2022-06-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, DiarrheaAdult check-in
- 2022-06-22
- 2022-06-24
- 2022-06-26
- 2022-06-27
- 2022-07-06
-
2022-07-18
Survey response — day 28, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: A coldMedDRA releases: 2024-11 · check-in free text available
- 2022-08-01
- 2022-09-21
-
2022-12-21
Survey response — 6 months, dose 2MedDRA: Nephrolithiasis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Kidney stonesMedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-12-22
- 2022-12-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-05-26 | Pfizer-BioNTech | No |
| 2 | 2022-06-20 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — day 28, dose 2
Symptoms: A cold
Release 12 — 6 months, dose 2
Symptoms: Kidney stones
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nephrolithiasis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release